Today
  • 08:12

    DUG Technology Ltd-US$33.7 Million Software and HPC Infrastructure Award

    08:12

    UBS CEO Sergio Ermotti Says AI Investors and Market Has Been Pricing Perfection Until Correction in Last Few Weeks

    08:09

    SBS Philippines - Qtrly Net Income Attributable 22.2 Mln Pesos

    08:08

    Trump: AI Risk Can Be Managed, but 'I Don't Mind Guardrails' -Cbs '60 Minutes' Interview

    08:04

    Rpt-RadNet Q3 EPS USD 0.05

    08:04

    Rpt-RadNet Q3 Pretax Profit USD 27.512 Million

    08:02

    Apollo Global Capital - 9M Loss 24.8 Mln Pesos

    08:01

    Japan Tobacco Shares Untraded Amid Glut of Sell Orders

    08:01

    Xtalpi - to Use AI and Robotics Platform for Novel Small Molecule Therapeutics

    08:01

    Xtalpi - Units Enter Research Collaboration Agreement With Pierre Fabre MÉDicament Sas

    08:01

    Xtalpi - Collaboration to Discover Novel Clinical Candidates in Oncology, Dermatology, and Rare Diseases

    08:01

    Xtalpi Holdings Ltd - AI-Driven Drug Discovery Collaboration Between Xtalpi and Laboratoires Pierre Fabre

    08:01

    Concrete Aggregates Corp - Qtrly Gross Revenue 21.7 Mln Pesos

    08:01

    Yield on 5-Year JGB Rises 5.5 Basis Points to 2.100%

    08:00

    Innovent Announces Phase 3 Credit-5 Study Met Primary Endpoint, Sintbilo® (Tafolecimab Injection) as First-Line Monotherapy Treatment for Hyperlipidemia Demonstrated Potent Lipid-Lowering Efficacy

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10